Product logins

Find logins to all Clarivate products below.


Dental Biomaterials – Market Insights – Europe (Supplemental)

The European dental biomaterial market will grow moderately through 2027, driven by an increasing number of GDs offering dental implant therapy and widespread awareness of dental implant treatments, leading to a greater volume of procedures incorporating dental biomaterials because bone grafting is often performed alongside dental implant placements. Companies in this space are also investing in innovative technologies to expand revenues and gain shares in this market. 

This Medtech 360 Report provides high-level market metrics for biosurgical agents in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Table of contents


Related Medtech Insights Reports

Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Large-Joint Reconstructive Implants – Market Insights – Europe
The European large-joint reconstructive implant market is poised for long-term sustained growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants,…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased…